tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Inari Medical, Inc. (NARI)
NASDAQ:NARI
US Market
NARI
Inari Medical
Overview
Analyst Forecasts
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Historical Prices
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Inari Medical (NARI) Stock Forecast & Price Target

Compare
326 Followers
See the Price Targets and Ratings of:

NARI Analyst Ratings

Hold
12Ratings
1 Buy
11 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Inari
Medical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NARI Stock 12 Month Forecast

Average Price Target

$75.33
▼(-5.80% Downside)
Based on 12 Wall Street analysts offering 12 month price targets for Inari Medical in the last 3 months. The average price target is $75.33 with a high forecast of $80.00 and a low forecast of $50.00. The average price target represents a -5.80% change from the last price of $79.97.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"39":"$39","60":"$60","81":"$81","49.5":"$49.5","70.5":"$70.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":80,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$80.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$75.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":50,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$50.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[39,49.5,60,70.5,81],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Aug<br/>2024","9":"Nov<br/>2024","12":"Feb<br/>2025","25":"Feb<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,79.67,79.69538461538461,79.72076923076924,79.74615384615385,79.77153846153847,79.79692307692308,79.82230769230769,79.84769230769231,79.87307692307692,79.89846153846153,79.92384615384616,79.94923076923077,79.97461538461539,{"y":80,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,79.67,79.33615384615385,79.0023076923077,78.66846153846154,78.33461538461539,78.00076923076924,77.66692307692308,77.33307692307692,76.99923076923076,76.66538461538461,76.33153846153846,75.9976923076923,75.66384615384615,{"y":75.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,79.67,77.3876923076923,75.10538461538462,72.82307692307693,70.54076923076923,68.25846153846155,65.97615384615385,63.69384615384615,61.41153846153846,59.12923076923077,56.846923076923076,54.56461538461539,52.2823076923077,{"y":50,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":57.72,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.4,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.18,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.6,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.19,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.87,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.23,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.63,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48.74,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.12,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.05,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.67,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$80.00Average Price Target$75.33Lowest Price Target$50.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
xxxxxxxxxxxxxxxxxx
Oppenheimer
Oppenheimer
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/08/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Jefferies
Jefferies
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/08/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Wells Fargo
Wells Fargo
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Piper Sandler
Piper Sandler
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Assigned
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Leerink Partners
Leerink Partners
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Reiterated
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Stifel Nicolaus
Stifel Nicolaus
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Reiterated
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Deutsche Bank
Deutsche Bank
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Canaccord Genuity
Canaccord Genuity
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
William Blair
William Blair
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
BTIG
BTIG
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Bank of America Securities Analyst forecast on NARI
Travis Steed
Bank of America Securities
$68
Buy
-14.97%
Downside
Reiterated
01/06/25
Bank of America Securities Keeps Their Buy Rating on Inari Medical (NARI)
Robert W. Baird Analyst forecast on NARI
David Rescott
Robert W. Baird
$81→$80
Hold
0.04%
Upside
Downgraded
01/06/25
Inari Medical downgraded to Neutral from Outperform at BairdInari Medical downgraded to Neutral from Outperform at Baird
Morgan Stanley Analyst forecast on NARI
Kallum Titchmarsh
Morgan Stanley
$60
Buy
-24.97%
Downside
Reiterated
11/01/24
Inari Medical's Strong Performance and Growth Catalysts Lead to Buy Rating
Needham Analyst forecast on NARI
Michael Matson
Needham
―
Hold
―
Assigned
10/29/24
Cautious Outlook on Inari Medical: Hold Rating Amid Mixed Q3 2024 Performance and Awaited PEERLESS Study Insights
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
xxxxxxxxxxxxxxxxxx
Oppenheimer
Oppenheimer
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/08/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Jefferies
Jefferies
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/08/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Wells Fargo
Wells Fargo
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Piper Sandler
Piper Sandler
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Assigned
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Leerink Partners
Leerink Partners
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Reiterated
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Stifel Nicolaus
Stifel Nicolaus
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Reiterated
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Deutsche Bank
Deutsche Bank
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
Canaccord Genuity
Canaccord Genuity
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
William Blair
William Blair
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxx
BTIG
BTIG
xxxxxxxxxxxxx
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Downgraded
01/07/25
xxxxxxxxxxxxx
xxxxxxxxxxxxx
Bank of America Securities Analyst forecast on NARI
Travis Steed
Bank of America Securities
$68
Buy
-14.97%
Downside
Reiterated
01/06/25
Bank of America Securities Keeps Their Buy Rating on Inari Medical (NARI)
Robert W. Baird Analyst forecast on NARI
David Rescott
Robert W. Baird
$81→$80
Hold
0.04%
Upside
Downgraded
01/06/25
Inari Medical downgraded to Neutral from Outperform at BairdInari Medical downgraded to Neutral from Outperform at Baird
Morgan Stanley Analyst forecast on NARI
Kallum Titchmarsh
Morgan Stanley
$60
Buy
-24.97%
Downside
Reiterated
11/01/24
Inari Medical's Strong Performance and Growth Catalysts Lead to Buy Rating
Needham Analyst forecast on NARI
Michael Matson
Needham
―
Hold
―
Assigned
10/29/24
Cautious Outlook on Inari Medical: Hold Rating Amid Mixed Q3 2024 Performance and Awaited PEERLESS Study Insights
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

NARI Analyst Recommendation Trends

Rating
Oct 24
Nov 24
Dec 24
Jan 25
Feb 25
Strong Buy
6
5
6
1
1
Buy
9
10
8
5
2
Hold
11
11
9
13
14
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
26
26
23
19
17
In the current month, NARI has received 3 Buy Ratings, 14 Hold Ratings, and 0 Sell Ratings. NARI average Analyst price target in the past 3 months is $75.33.
Each month's total comprises the sum of three months' worth of ratings.

NARI Financial Forecast

NARI Earnings Forecast

Next quarter’s earnings estimate for NARI is -$0.11 with a range of -$0.24 to $0.02. The previous quarter’s EPS was -$0.08. NARI beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 51.92% of the time in the same period. In the last calendar year NARI has Outperformed its overall industry.
Next quarter’s earnings estimate for NARI is -$0.11 with a range of -$0.24 to $0.02. The previous quarter’s EPS was -$0.08. NARI beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 51.92% of the time in the same period. In the last calendar year NARI has Outperformed its overall industry.

NARI Sales Forecast

Next quarter’s sales forecast for NARI is $161.23M with a range of $160.70M to $161.50M. The previous quarter’s sales results were $153.39M. NARI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.82% of the time in the same period. In the last calendar year NARI has Outperformed its overall industry.
Next quarter’s sales forecast for NARI is $161.23M with a range of $160.70M to $161.50M. The previous quarter’s sales results were $153.39M. NARI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 50.82% of the time in the same period. In the last calendar year NARI has Outperformed its overall industry.

NARI Stock Forecast FAQ

What is NARI’s average 12-month price target, according to analysts?
Based on analyst ratings, Inari Medical, Inc.’s 12-month average price target is $75.33.
    What is NARI’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for NARI, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is NARI a Buy, Sell or Hold?
        Inari Medical, Inc. has a consensus rating of Hold which is based on 1 buy ratings, 11 hold ratings and 0 sell ratings.
          What is Inari Medical, Inc.’s price target?
          The average price target for Inari Medical, Inc. is $75.33. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $80.00 ,the lowest forecast is $50.00. The average price target represents -5.80% Decrease from the current price of $79.97.
            What do analysts say about Inari Medical, Inc.?
            Inari Medical, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.
              How can I buy shares of NARI?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

                Become an Expert with TipRanks Premium

                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis
                Subscribe NowSee Plans & Pricing